BiochemistrybioRxiv
Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery
C. N. Russell, J. L. Carter, J. M. Borgia…·N. G. Jones
This paper identifies LdBDF5 as a potential drug target for antileishmanial therapy by showing its interaction with human bromodomain inhibitors and demonstrating antipromastigote activity of SGC-CBP30.
DOI 10.1021/acsinfecdis.3c00431